Pulmicort Respules

See also: Generic Pulmicort Flexhaler, Generic Pulmicort Turbuhaler

Pulmicort Respules is a brand name of budesonide, approved by the FDA in the following formulation(s):

PULMICORT RESPULES (budesonide - suspension; inhalation)

• 
  Manufacturer: ASTRAZENECA
  
  Approval date: August 8, 2000
  
  Strength(s): 0.25MG/2ML ^[AN], 0.5MG/2ML ^[AN], 1MG/2ML ^[RLD]

Has a generic version of Pulmicort Respules been approved?

A generic version of Pulmicort Respules has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Pulmicort Respules and have been approved by the FDA:

budesonide suspension; inhalation

• 
  Manufacturer: APOTEX
  
  Approval date: March 30, 2009
  
  Strength(s): 0.25MG/2ML ^[AN], 0.5MG/2ML ^[AN]


• 
  Manufacturer: TEVA PARENTERAL
  
  Approval date: November 18, 2008
  
  Strength(s): 0.25MG/2ML ^[AN], 0.5MG/2ML ^[AN]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Pulmicort Respules. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Method for treating respiratory diseases
  Patent 6,598,603
  Issued: July 29, 2003
  Inventor(s): Bertil; Andersson & Thor-Björn; Conradsson & Göran; Eriksson
  Assignee(s): Astra Aktiebolag
  The invention provides a novel method of treating respiratory diseases, e.g., pediatric asthma, in a continuing regimen with not more than one daily dose of the drug budesonide using a nebulizer.
  
  Patent expiration dates:
  
  
  • December 23, 2018
    
    ✓ 
    Patent use: ONCE DAILY TREATMENT OF ASTHMA WITH NEBULIZED BUDESONIDE
  
  
  
  • June 23, 2019
    
    ✓ 
    Pediatric exclusivity
  
  



• 
  Method for treating a respiratory disease
  Patent 6,899,099
  Issued: May 31, 2005
  Inventor(s): Andersson; Bertil & Conradsson; Thor-Björn & Eriksson; Göran
  Assignee(s): AstraZeneca AB
  The invention provides a novel method of treating respiratory diseases, e.g., pediatric asthma, in a continuing regimen with not more than one daily dose of the drug budesonide using a nebulizer.
  
  Patent expiration dates:
  
  
  • December 23, 2018
    
    ✓ 
    Patent use: ONCE DAILY TREATMENT OF ASTHMA WITH NEBULIZED BUDESONIDE
  
  
  
  • June 23, 2019
    
    ✓ 
    Pediatric exclusivity
  
  



• 
  Sterile powders, formulations, and methods for producing the same
  Patent 7,524,834
  Issued: April 28, 2009
  Inventor(s): Karlsson; Ann-Kristin & Larrivee-Elkins; Cheryl & Molin; Ove
  Assignee(s): AstraZeneca AB
  The invention provides sterile glucocorticosteroids and sterile formulations containing glucocorticosteroid and use thereof in the treatment of an allergic and/or inflammatory condition of the nose or the lungs.
  
  Patent expiration dates:
  
  
  • November 11, 2018
    
    ✓ 
    Patent use: TREATMENT OF ASTHMA (MAINTENANCE AND PROPHYLACTIC THERAPY)
    ✓ 
    Drug product
  
  
  
  • May 11, 2019
    
    ✓ 
    Pediatric exclusivity
  
  

See also...

• Pulmicort Respules Suspension Consumer Information (Wolters Kluwer)
• Pulmicort Respules Consumer Information (Cerner Multum)
• Pulmicort Respules Advanced Consumer Information (Micromedex)
• Budesonide Powder Consumer Information (Wolters Kluwer)
• Budesonide Suspension Consumer Information (Wolters Kluwer)
• Budesonide Sustained-Release Capsules Consumer Information (Wolters Kluwer)
• Budesonide Consumer Information (Cerner Multum)
• Budesonide inhalation Consumer Information (Cerner Multum)
• Pulmicort Spacer Advanced Consumer Information (Micromedex)
• Rhinocort Turbuhaler Advanced Consumer Information (Micromedex)
• Budesonide Advanced Consumer Information (Micromedex)
• Budesonide Inhalation Advanced Consumer Information (Micromedex)
• Budesonide AHFS DI Monographs (ASHP)